Tenaya Therapeutics' SVP & Interim PAO Chihiro Saito resigns effective Dec 16, 2024

Tenaya Therapeutics, Inc.

Chihiro Saito resigned as SVP, Accounting and Financial Operations and Interim Principal Accounting Officer.
Resignation is to pursue another opportunity; not due to any disagreement with Tenaya.
No replacement or timeline for successor announced in the filing.
Departure leaves interim accounting leadership role vacant at the biotech firm.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.